SKYRIZI Helps Deliver




*At least a 50% visible improvement of the intestinal lining

What is SKYRIZI?

See the Science

Results With SKYRIZI

See the Data
Person using blue phone

How to Take SKYRIZI

Get Dosing Details
Person using blue phone

Save With Complete

Learn More
“S” Icon

A New Treatment for Crohn’s Is Here

With SKYRIZI symptom relief, lasting remission at 1 year, and endoscopic improvement may be achievable.

endoscopic improvement

At least a 50% visible improvement of the intestinal lining.

Calendar Icon

Only 6 Doses A Year

After 3 Starter Doses

SKYRIZI can fit into your schedule with at-home dosing every 8 weeks, after a total of 3 intravenous (IV) starter doses and proper training from your healthcare professional.

Operator Icon

Your Dedicated Nurse Ambassador*

Your Skyrizi Complete Nurse Ambassador is committed to getting to know you and your individual SKYRIZI needs.

*Nurse Ambassadors are provided by AbbVie and do not work under the direction of your health care professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals.


What’s most important to you when looking for a new Crohn’s treatment?

Symptom relief

Did you know in clinical studies, SKYRIZI helped patients achieve clinically-proven symptom relief at 12 weeks? Click below to learn more about SKYRIZI.

See SKYRIZI Results

Its safety profile

Ask your doctor about the benefits and risks of SKYRIZI.
Before making a decision, get the facts.

See SKYRIZI Side Effects

How it works

SKYRIZI is a treatment that works differently by specifically targeting the IL-23 protein, which is one of the key proteins responsible for inflammation. By targeting IL-23, SKYRIZI can help reduce the excess inflammation that may contribute to Crohn’s symptoms.

See How SKYRIZI Works

Brochure Icon

Start the Conversation

Get the information you need to talk to your doctor about Crohn’s—and learn how SKYRIZI can help.

Download the Brochure